Emerging Infectious Diseases (Jun 2017)

Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States

  • Cheryl P. Andam,
  • Colin J. Worby,
  • Ryan Gierke,
  • Lesley McGee,
  • Tamara Pilishvili,
  • William P. Hanage

DOI
https://doi.org/10.3201/eid2306.161331
Journal volume & issue
Vol. 23, no. 6
pp. 1012 – 1015

Abstract

Read online

Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.

Keywords